Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn's disease patients over three years.

Sci Rep · 2024 · PMC11213936 · PMID 38942890

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In harmony with this, systemic corticosteroid therapy augmenting the UST treatment showed a decreasing trend with 12.8%, 7.4%, and 5.4%.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.